SCHEMBL3268680

SCHEMBL3268680

CC(=O)Oc1cc(C)c(C=O)c(C)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
HTT P42858 2/20 0.46
PTPN1 P18031 3/20 0.43
CYP3A4 P08684 2/20 0.43
PTGES O14684 1/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
CASP1 P29466 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GAA P10253 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GLA P06280 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11458363 0.79 ALDH1A1 (0.43) POLBHTTFNTAFNTBKDM4E
SCHEMBL4551009 0.77 ALDH1A1 (0.44) PTPN1CYP3A4PTGESKDM4EALDH1A1
SCHEMBL2910532 0.77 POLB (0.62) POLBHTTPTPN1KDM4EALDH1A1
SCHEMBL12587651 0.77 GRIN2D (0.47) POLBHTTCYP3A4FNTAFNTB
SCHEMBL15642113 0.76 POLB (0.65) POLBHTTPTPN1CYP3A4KDM4E
SCHEMBL2912166 0.76 POLB (0.56) POLBHTTPTPN1CYP3A4KDM4E
SCHEMBL3268021 0.76 LMNA (0.45) POLBCYP3A4KDM4EALDH1A1MAPT
SCHEMBL16666424 0.74 POLB (0.58) POLBHTTPTPN1CYP3A4KDM4E
SCHEMBL15867097 0.74 ACHE (0.57) POLBHTTKDM4EALDH1A1MAPT
SCHEMBL9844974 0.74 POLB (0.50) POLBHTTPTPN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 POLB 4801/4885HTT 4846/4885PTPN1 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.